Published in J Cardiovasc Electrophysiol on March 01, 2005
Brugada syndrome. Pacing Clin Electrophysiol (2006) 2.61
Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay. Circulation (2011) 1.60
Brugada syndrome in childhood: a potential fatal arrhythmia not always recognised by paediatricians. A case report and review of the literature. Eur J Pediatr (2006) 0.82
Prolonged QTc interval in association with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics (2014) 0.78
Recurrent Ventricular Tachycardia in Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency. JIMD Rep (2015) 0.75
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 8.76
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm (2009) 4.99
Brugada syndrome: report of the second consensus conference. Heart Rhythm (2005) 2.48
Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol (2003) 2.44
Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol (2005) 2.39
De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res (2005) 2.27
Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol (2012) 2.26
Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet (2002) 2.16
Effect of opening a new catheterization laboratory on 30-day and 2-year survival rates in myocardial infarction patients. Rev Esp Cardiol (2011) 2.14
Familial pseudo-Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol (2006) 2.11
Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation (2005) 1.94
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation (2003) 1.92
Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm (2006) 1.91
Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation (2002) 1.91
Short QT syndrome: pharmacological treatment. J Am Coll Cardiol (2004) 1.87
Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol (2004) 1.81
Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation (2008) 1.81
Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol (2005) 1.74
Electrophysiologic testing predicts events in Brugada syndrome patients. Heart Rhythm (2011) 1.70
Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:. J Cardiovasc Electrophysiol (2004) 1.69
Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol (2008) 1.67
IDH2 mutations in patients with D-2-hydroxyglutaric aciduria. Science (2010) 1.63
State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol (2011) 1.61
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. Heart Rhythm (2006) 1.56
Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol (2003) 1.54
Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol (2007) 1.52
Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res (2011) 1.51
The cloning, genomic organization and tissue expression profile of the human DLG5 gene. BMC Genomics (2002) 1.50
Fever and Brugada syndrome. Pacing Clin Electrophysiol (2002) 1.48
Shocking truths about implantable cardioverter defibrillator monitoring zones. Pacing Clin Electrophysiol (2007) 1.48
Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace (2013) 1.47
Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol (2011) 1.47
KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders. Heart Rhythm (2009) 1.43
Rebuttal to EP testing does not predict cardiac events in patients with Brugada syndrome. Heart Rhythm (2011) 1.39
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res (2009) 1.28
Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation (2004) 1.14
Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol (2009) 1.11
Brugada syndrome unmasked by pneumonia. Tex Heart Inst J (2006) 1.10
Genetic modulation of brugada syndrome by a common polymorphism. J Cardiovasc Electrophysiol (2009) 1.09
Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation (2006) 1.08
Brugada syndrome: from cell to bedside. Curr Probl Cardiol (2005) 1.08
Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation. Epilepsy Res (2013) 1.04
Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm (2007) 1.04
Brugada syndrome. Prog Cardiovasc Dis (2008) 1.03
Brugada syndrome: update 2009. Hellenic J Cardiol (2009) 1.03
Genetics and cardiac channelopathies. Genet Med (2010) 1.00
Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. Circ Res (2008) 1.00
Autopsy investigation and Bayesian approach to coronary artery disease in victims of motor-vehicle accidents. Atherosclerosis (2011) 1.00
Atrial fibrillation: evidence for genetically determined disease. Curr Opin Cardiol (2008) 0.99
Analysis of mRNA from human heart tissue and putative applications in forensic molecular pathology. Forensic Sci Int (2010) 0.98
Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut. Mol Genet Metab (2010) 0.96
Novel mutations in domain I of SCN5A cause Brugada syndrome. Mol Genet Metab (2002) 0.94
Genetics and arrhythmias. Annu Rev Med (2002) 0.94
Negative autopsy and sudden cardiac death. Int J Legal Med (2014) 0.93
A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. Heart Rhythm (2008) 0.92
The rat heart contains a neural stem cell population; role in sympathetic sprouting and angiogenesis. J Mol Cell Cardiol (2008) 0.91
Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome. J Cardiovasc Electrophysiol (2008) 0.90
Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm (2008) 0.89
Genetics of Brugada syndrome. Curr Opin Cardiol (2010) 0.89
The cardiac sodium channel is post-translationally modified by arginine methylation. J Proteome Res (2011) 0.89
A missense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome. Hum Mutat (2013) 0.88
Validation of warfarin pharmacogenetic algorithms in clinical practice. Pharmacogenomics (2012) 0.88
Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada. Can J Public Health (2008) 0.88
Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death. Epilepsia (2013) 0.87
Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised. Eur Heart J (2010) 0.87
Genetics of arrhythmogenic right ventricular cardiomyopathy. J Med Genet (2013) 0.87
Channelopathies: a new category of diseases causing sudden death. Herz (2007) 0.87
Heart rate variability analysis indicates preictal parasympathetic overdrive preceding seizure-induced cardiac dysrhythmias leading to sudden unexpected death in a patient with epilepsy. Epilepsia (2014) 0.87
Mild Beckwith-Wiedemann and severe long-QT syndrome due to deletion of the imprinting center 2 on chromosome 11p. Eur J Hum Genet (2013) 0.86
Increase in sudden death from coronary artery disease in young adults. Am Heart J (2011) 0.85
Newborn screening by tandem mass spectrometry: ethical and social issues. Can J Public Health (2007) 0.85
Sarcomeric gene mutations in sudden infant death syndrome (SIDS). Forensic Sci Int (2012) 0.85
Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy. Clin Res Cardiol (2014) 0.85
Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series. Int J Legal Med (2014) 0.85
Mutation-based diagnostic testing for primary hyperoxaluria type 1: survey of results. Clin Biochem (2008) 0.84
Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation. Heart Rhythm (2010) 0.84
Arrhythmia and right heart disease: from genetic basis to clinical practice. Rev Esp Cardiol (2010) 0.84
Genetic basis of ventricular arrhythmias. Cardiol Clin (2008) 0.84
Protein arginine methyl transferases-3 and -5 increase cell surface expression of cardiac sodium channel. FEBS Lett (2013) 0.83
Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking. Orphanet J Rare Dis (2014) 0.83
Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm. J Interv Card Electrophysiol (2008) 0.82
Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β-oxidation disorders in adult patients with rhabdomyolysis. J Inherit Metab Dis (2013) 0.81
DiBAC₄(3) hits a "sweet spot" for the activation of arterial large-conductance Ca²⁺-activated potassium channels independently of the β₁-subunit. Am J Physiol Heart Circ Physiol (2013) 0.81
Prediction of obstetrical risk using maternal serum markers and clinical risk factors. Prenat Diagn (2013) 0.81
Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammation. J Clin Pathol (2012) 0.81
Long-term outcomes of blood phenylalanine concentrations in children with classical phenylketonuria. Mol Genet Metab (2013) 0.80
Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J (2007) 0.80
Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene. Mol Genet Metab (2011) 0.80
A Genetically Vulnerable Myocardium May Predispose to Myocarditis. J Am Coll Cardiol (2015) 0.79
A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome. PLoS One (2013) 0.79
Genetics of familial atrial fibrillation. Europace (2009) 0.79
Molecular heterogeneity of large-conductance calcium-activated potassium channels in canine intracardiac ganglia. Channels (Austin) (2013) 0.79
Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome. J Cardiovasc Med (Hagerstown) (2007) 0.79
Brugada syndrome: diagnostic pitfalls. J Emerg Med (2009) 0.78
Cardiovascular translational medicine (IV): The genetic basis of malignant arrhythmias and cardiomyopathies. Rev Esp Cardiol (2009) 0.78
Nestin (+) stem cells independently contribute to neural remodelling of the ischemic heart. J Cell Physiol (2011) 0.78